Holen Sie sich die Stockscreener-App
0.7459
2.18%
0.0159
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
AEONAEON Biopharma Inc Latest SEC Filings - Finviz
Price to book forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView
Enterprise value to revenue forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView
AEON Biopharma, Inc. Class A Actuals & Estimates (AMEX:AEON) - TradingView
AEON Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Aeon Biopharma Inc For: 22 June By Investing.com - Investing.com Nigeria
[Form 4] AEON Biopharma, Inc. Insider Trading Activity - Stock Titan
AEON Biopharma (AEON) grants 222,684 RSUs to director Palmisano - Stock Titan
Director at AEON Biopharma (AEON) granted 222,684 RSUs - Stock Titan
AEON Biopharma (AEON) director awarded 222,684 RSUs in equity grant - Stock Titan
Director Carter granted 222,684 RSUs at AEON Biopharma (AEON) - Stock Titan
Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AEON BIOPHARMA INC (AEON) Stock Chart - ChartMill
AEON Biopharma shareholders approve directors and auditor slate - TipRanks
Aeon Biopharma Inc (AEON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aeon Biopharma Inc (AEON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aeon Biopharma Inc (AEON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AEON Biopharma, Inc. Elects Each of Marc Forth and Seongsoo Park as Class III Directors of the Company's Board of Directors - marketscreener.com
AEON Biopharma (NYSE: AEON) investors back Class III board slate and KPMG - Stock Titan
Aeon Biopharma Inc (AEON) Institutional Confidence - TradingKey
Aeon Biopharma Inc (AEON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aeon Biopharma Inc (AEON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aeon Biopharma Inc (AEON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AEON Biopharma (AEON) Slides 7% as Selling Pressure Intensifies Near $0.67Wave Extension - newsline.com
AEON Biopharma (AEON) Holds Steady at $0.71 as Stock Consolidates Between Key Support and ResistanceSeasonality Effect - newsline.com
AEON Q4 2025 Earnings: Significant EPS Miss as Pre-Revenue Biotech Faces ChallengesRetail Earnings Report - newsline.com
Number of shareholders of AEON Biopharma, Inc. – AMEX:AEON - TradingView
AEON Biopharma Presents New Data Supporting Biosimilarity of ABP-450 to BOTOX at AHS 2026 Annual Meeting - Moomoo
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society - The Manila Times
Botox biosimilar ABP-450 shows similar structure and activity - Stock Titan
AEON Biopharma Presents New Data Supporting Biosimilarity of ABP-450 to BOTOX® at AHS 2026 Annual Meeting - Quiver Quantitative
AEON Technical Analysis | Trend, Signals & Chart Patterns | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON Biopharma (AEON) Surges 5.6% as Bulls Test Key Resistance at $0.80Factor ETF Flow - newsline.com
AEON Biopharma Edges Higher: Stock Rises 2.75% as it Tests Key ResistanceHigh Conviction Picks - The Legal Advocate
AEON Q4 2025 Earnings: Deep EPS Miss Amid Pre-Revenue StageEPS Miss Report - The Legal Advocate
AEON Biopharma Q4 2025 Earnings: Major EPS Miss and No Revenue Weigh on Investor SentimentEarnings Expansion Phase - Newser
AEON Biopharma Inc. (AEON) Q4 2025 Earnings: Significant EPS Miss and Stock Decline Amid Development ChallengesHigh Growth Earnings - Newser
AEON Biopharma Dips 2.74% as Stock Nears Critical Support at $0.76Watchlist Stock Ideas - Newser
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
AEON Stock Price, Quote & Chart | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON SEC FilingsAeon Biopharma 10-K, 10-Q, 8-K Forms - Stock Titan
AEON Biopharma shares fall over 2% on quarterly loss By Investing.com - Investing.com South Africa
AEON Biopharma shares fall over 2% on quarterly loss - Investing.com
AEON Biopharma Reports Q1 Financial Results - Intellectia AI
AEON Biopharma Releases Updated Investor Relations Presentation - TipRanks
AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma (AEON) releases May 2026 corporate investor presentation via Form 8-K - Stock Titan
AEON Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
AEON Biopharma (NYSE: AEON) Q1 2026 loss, financing deals and going concern risk - Stock Titan
AEON Biopharma (NYSE: AEON) Q1 2026 loss, FDA boosts ABP-450 plan and debt cut - Stock Titan
1.95%
0.07%
Kapitalisierung:
|
Volumen (24h):